Fluorescently labeled antibodies bind selected cell-surface or intracellular markers, allowing researchers to distinguish immune populations and characterize their phenotype. Surface markers reveal features exposed on the cell, whereas intracellular markers provide information from within the cell. This distinction helps analysis move beyond simple cell counts and identify biologically different immune populations.
Phenotypic measurements describe which markers immune cells carry and how abundant particular populations are. Functional assays instead examine what those cells do, such as producing cytokines, proliferating, or displaying cytotoxicity. Combining both perspectives can show whether a population is merely present or is actively responding in a biologically meaningful way.
Innate and adaptive immune populations can respond differently to pathogens, vaccination, or treatment, so separating them provides more informative interpretation than evaluating immune cells as one group. Measuring changes in each population can reveal which arm of immunity is associated with a response, supporting analysis of immune protection and treatment-related effects.
A supported workflow begins by identifying and measuring immune cell populations, then characterizing their markers with fluorescently labeled antibodies when appropriate. Functional assays can follow to assess cytokine production, proliferation, or cytotoxicity. Reviewing abundance, phenotype, and function together produces a more complete assessment than relying on any single measurement type.
In infection research, these measurements help determine how immune populations respond to pathogens and how those responses change after vaccination or treatment. Researchers can examine population abundance, marker-defined phenotype, and functional activity to profile disease-related immune changes. The resulting information may help evaluate immune protection or identify responses associated with intervention.
The resulting measurements can support disease profiling, biomarker discovery, evaluation of immune protection, and development of targeted therapies. Abundance data may describe the scale of an immune response, phenotype data may identify distinguishing cellular features, and functional results may indicate activity such as cytokine production, proliferation, or cytotoxicity.